Laxxon Medical, a leading pharmaceutical technology company specializing in advanced oral drug delivery systems, is participating in the Jefferies Healthcare Conference in London, running from November 17 to 20, 2025. This high-profile event, recognized as one of the premier global partnering forums for the life sciences industry, attracts top-tier industry executives, decision-makers, and innovators from across Europe and beyond. Laxxon Medical's presence at the conference underscores its commitment to innovation and strategic collaboration within the hospital and healthcare sector, with a particular emphasis on pharmaceuticals, healthcare information technology, and patient monitoring emergency care.

At the conference, Laxxon Medical is showcasing its proprietary SPID®-Technology pharmaceutical printing platform, a disruptive innovation that enables controlled drug release profiles and significantly enhances bioavailability. This technology utilizes a sophisticated screen-printing process to manufacture next-generation oral pharmaceuticals efficiently. SPID®-Technology offers healthcare organizations a pathway to accelerate product development and fast-track market access, leveraging regulatory mechanisms under both EU Directive 2001/83/EC and the FDA's 505b(2) route. Laxxon Medical's pipeline includes 13 in-house advanced patented generics and strategic collaborations with major pharmaceutical companies, biotech firms, and leading research universities. The company's intellectual property portfolio is robust, with more than 230 patents and patent applications and over 5,000 patent claims, positioning it as a key innovation partner for hospitals seeking novel therapeutic solutions.

For hospital administrators, clinical leadership, and procurement professionals, Laxxon Medical’s developments offer tangible benefits. The company’s technology facilitates precise dosing, customizable drug release, and potential reductions in medication-related adverse events—critical factors for improving patient safety and operational efficiency in hospital pharmacies. The ability to work with both new and existing pharmaceuticals, while extending patent lifecycles, also provides healthcare facilities with strategic procurement and formulary options, enhancing supply chain resilience in an era of frequent medicine shortages. Additionally, Laxxon Medical’s commitment to regulatory compliance, with pathways designed to streamline both EU and US approvals, addresses a vital concern for health system managers tasked with ensuring timely access to innovative treatments.

At Jefferies Healthcare Conference, Laxxon Medical aims to engage with stakeholders responsible for strategic partnerships, technology deployments, and investment decisions. The company invites attendees to schedule meetings to discuss tailored solutions, technology transfer opportunities, and co-development initiatives. These discussions are particularly relevant for hospital pharmacy leaders and healthcare technology vendors who seek to enhance medication management, optimize delivery systems, and invest in long-term infrastructure upgrades. By facilitating multidisciplinary collaborations, Laxxon Medical is poised to play a significant role in shaping the future of pharmaceutical care and digital transformation in European hospitals.

Industry experts and hospital managers attending the conference have an opportunity to network with Laxxon Medical’s executive team, assess the potential of advanced drug printing platforms for their organizations, and explore joint ventures that promise to revolutionize the delivery of care across hospital settings. The conference’s agenda includes sessions dedicated to supply chain innovations, regulatory dynamics, and the integration of digital health solutions—aligning closely with Laxxon Medical’s mission. In summary, Laxxon Medical’s participation in this event highlights a strategic focus on leveraging breakthrough technologies to solve pressing challenges in drug development, hospital pharmacy operations, and medication safety for healthcare organizations throughout Europe.